Seiji Futagami, Shuhei Agawa, Ken Nakamura, Yoshiyuki Watanabe, Mayu Habiro, Rie Kawawa, Hiroshi Yamawaki, Rina Tsushima, Kumiko Kirita, Teppei Akimoto, Nobue Ueki, Tanabe Tomohide, Norio Itokawa, Nami Suzuki, Yutaka Naito, Keiko Takeuchi, Ayumi Kashiro, Ryu Ohta, Satoshi Mizutani, Nobuhiko Taniai, Hiroshi Yoshida, Katsuhiko Iwakiri, Kazufumi Honda
BACKGROUND AND AIM: Apolipoprotein A2 (apoA2) isoforms have been reported to undergo the aberrant processing in pancreatic cancer and pancreatic risk populations compared with that in healthy subjects. This study aimed to clarify whether apoA2 isoforms were as useful as N-benzoyl-p-aminobenzoic acid (BT-PABA) test for exocrine pancreatic dysfunction markers in patients with early chronic pancreatitis (ECP). METHODS: Fifty consecutive patients with functional dyspepsia with pancreatic enzyme abnormalities (FD-P) (n = 18), with ECP (n = 20), and asymptomatic patients with pancreatic enzyme abnormalities (AP-P) (n = 12) based on the Rome IV classification and the Japan Pancreatic Association were enrolled in this study...
July 27, 2023: Journal of Gastroenterology and Hepatology